Bankruptcy News

Stay up to date on corporate Chapter 7 and Chapter 11 bankruptcy activity with these breaking, actionable news reports.

Healthcare Equipment & Services

Unigene Laboratories Chapter 7 Petition Filed

July 2, 2013
/ Print /
| Share More
/ Text Size+

Unigene Laboratories filed for Chapter 7 protection with the U.S. Bankruptcy Court in the District of New Jersey, case number 13-24696. The Company, which engages in biopharmaceutical research, production and drug delivery of small proteins referred to as peptides for therapeutic use, is represented by Matthew E. Tashman of Reed Smith. As a result of the bankruptcy filing, a Chapter 7 trustee will be appointed by the Court and will assume control of the Company. All remaining assets of the Company will be liquidated in accordance with the Bankruptcy Code. According to documents filed with the SEC, concurrent with the Chapter 7 filing, the employment of all remaining employees of the Company, including Ashleigh Palmer, president and C.E.O., and Jack Wyszomierski, C.F.O., treasurer and secretary, was terminated. As a result, the Company no longer has any employees. In addition, Richard Levy, Ashleigh Palmer, Thomas J. Sabatino, Jr., Joel A. Tune and Jack Wyszomierski resigned from the board, and the Company has no current board members.  

Read more Bankruptcy News

Free Report

George Putnam has suceessfully invested in distressed companies for nearly 30 years and The Turnaround Letter's market-beating returns demonstrate the profit potential. He knows all the pitfalls, too--which he shares in this free report!

stock market advice

stock market advice

Distressed Investing Blog

Distressed Investing Blog

Are the "Experts" Usually Wrong? Time to Buy Emerging Markets?

If you look longer-term--both backwards and forwards--emerging markets look like much more promising investments...and many of the stocks have decent dividend yields to compensate you in case you have to wait a while for a rebound. Read More.

Your Financial Security is Serious Business...

so why should you trust The Turnaround Letter?

  • Ranked as #1 Performing Newsletter for 15-Yr. Returns: Turnaround Letter's 12.3% vs. S&P's 2.2%
  • 29+ Years of Turnaround Investing Experience & Reliable Stock Market Advice
  • Diverse Monthly Stock Picks Personally Selected by George Putnam

Act Now on Tax Losses

Beat Year-End Bounce Rush


With all the stock market volatility this year, many investors probably find themselves holding some stocks in which they have sizable losses. By selling those losers and realizing losses, you can use those losses to offset taxable gains that you may have realized during the year.

Value Stock Profit

Most individual investors consider this investing strategy in December, which means that this tax-loss selling could push the price of some of these stocks even lower--meaning you probably do not want to be selling your losers then. In fact, savvy contrarians should consider buying some of these beaten down stocks to take advantage of that tax-generated downward pressure that goes away on January first.